Elise T. Wang

Elise T. Wang

Directeur/Bestuurslid bij
Jaguar Gene Therapy LLC
66 jaar
Finance
Health Technology
Consumer Services

Profiel

Ms. Elise T.
Wang
is a Partner & Head of Private Equity Capital Markets at Deerfield Management Co. LP.
Ms. Wang provides research and analysis on individual companies operating in the healthcare industry in both the US and Europe.
Ms. Wang is a board member of Jaguar Gene Therapy.
Prior to Deerfield, Ms. Wang was a Senior Research Analyst and Managing Director covering the biotechnology sector at PaineWebber and Citigroup.
She began her career in healthcare as a venture capitalist and banker at PaineWebber and was an officer of PaineWebber Development Corporation, which managed nearly $1 billion in assets representing three PaineWebber funds and several research and development limited partnerships (RDLPs) invested in biotechnology and high technology companies.
Ms. Wang holds an A.B. in Engineering Sciences with a specialty in Biomechanics from Harvard University and an M.B.A. from Harvard Business School.

Actieve functies van Elise T. Wang

BedrijvenFunctieBegin
Analyst-Equity 01-01-2010
Directeur/Bestuurslid -

Eerdere bekende functies van Elise T. Wang

BedrijvenFunctieEinde
ORCHARD THERAPEUTICS PLC Directeur/Bestuurslid 30-10-2018
Analyst-Equity 31-12-2006
Corporate Officer/Principal 01-01-2001
Corporate Officer/Principal -
WEREWOLF THERAPEUTICS, INC. Directeur/Bestuurslid -
Ervaring van Elise T. Wang in detail bekijken

Opleiding van Elise T. Wang

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

99

Eerstegraads connecties

10

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit10

Finance

Finance

Consumer Services

Commercial Services

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Services

  1. Beurs
  2. Insiders
  3. Elise T. Wang
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU